ID   NUAK1_HUMAN             Reviewed;         661 AA.
AC   O60285; A7MD39; Q96KA8;
DT   20-JUN-2001, integrated into UniProtKB/Swiss-Prot.
DT   01-AUG-1998, sequence version 1.
DT   12-APR-2017, entry version 159.
DE   RecName: Full=NUAK family SNF1-like kinase 1;
DE            EC=2.7.11.1;
DE   AltName: Full=AMPK-related protein kinase 5;
DE            Short=ARK5;
DE   AltName: Full=Omphalocele kinase 1;
GN   Name=NUAK1; Synonyms=ARK5, KIAA0537, OMPHK1;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), FUNCTION, ENZYME REGULATION,
RP   PHOSPHORYLATION AT THR-211, AND MUTAGENESIS OF THR-211.
RX   PubMed=14976552; DOI=10.1038/sj.emboj.7600110;
RA   Lizcano J.M., Goeransson O., Toth R., Deak M., Morrice N.A.,
RA   Boudeau J., Hawley S.A., Udd L., Maekelae T.P., Hardie D.G.,
RA   Alessi D.R.;
RT   "LKB1 is a master kinase that activates 13 kinases of the AMPK
RT   subfamily, including MARK/PAR-1.";
RL   EMBO J. 23:833-843(2004).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Brain;
RX   PubMed=9628581; DOI=10.1093/dnares/5.1.31;
RA   Nagase T., Ishikawa K., Miyajima N., Tanaka A., Kotani H., Nomura N.,
RA   Ohara O.;
RT   "Prediction of the coding sequences of unidentified human genes. IX.
RT   The complete sequences of 100 new cDNA clones from brain which can
RT   code for large proteins in vitro.";
RL   DNA Res. 5:31-39(1998).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 1 AND 2).
RC   TISSUE=Hippocampus;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16541075; DOI=10.1038/nature04569;
RA   Scherer S.E., Muzny D.M., Buhay C.J., Chen R., Cree A., Ding Y.,
RA   Dugan-Rocha S., Gill R., Gunaratne P., Harris R.A., Hawes A.C.,
RA   Hernandez J., Hodgson A.V., Hume J., Jackson A., Khan Z.M.,
RA   Kovar-Smith C., Lewis L.R., Lozado R.J., Metzker M.L.,
RA   Milosavljevic A., Miner G.R., Montgomery K.T., Morgan M.B.,
RA   Nazareth L.V., Scott G., Sodergren E., Song X.-Z., Steffen D.,
RA   Lovering R.C., Wheeler D.A., Worley K.C., Yuan Y., Zhang Z.,
RA   Adams C.Q., Ansari-Lari M.A., Ayele M., Brown M.J., Chen G., Chen Z.,
RA   Clerc-Blankenburg K.P., Davis C., Delgado O., Dinh H.H., Draper H.,
RA   Gonzalez-Garay M.L., Havlak P., Jackson L.R., Jacob L.S., Kelly S.H.,
RA   Li L., Li Z., Liu J., Liu W., Lu J., Maheshwari M., Nguyen B.-V.,
RA   Okwuonu G.O., Pasternak S., Perez L.M., Plopper F.J.H., Santibanez J.,
RA   Shen H., Tabor P.E., Verduzco D., Waldron L., Wang Q., Williams G.A.,
RA   Zhang J., Zhou J., Allen C.C., Amin A.G., Anyalebechi V., Bailey M.,
RA   Barbaria J.A., Bimage K.E., Bryant N.P., Burch P.E., Burkett C.E.,
RA   Burrell K.L., Calderon E., Cardenas V., Carter K., Casias K.,
RA   Cavazos I., Cavazos S.R., Ceasar H., Chacko J., Chan S.N., Chavez D.,
RA   Christopoulos C., Chu J., Cockrell R., Cox C.D., Dang M.,
RA   Dathorne S.R., David R., Davis C.M., Davy-Carroll L., Deshazo D.R.,
RA   Donlin J.E., D'Souza L., Eaves K.A., Egan A., Emery-Cohen A.J.,
RA   Escotto M., Flagg N., Forbes L.D., Gabisi A.M., Garza M., Hamilton C.,
RA   Henderson N., Hernandez O., Hines S., Hogues M.E., Huang M.,
RA   Idlebird D.G., Johnson R., Jolivet A., Jones S., Kagan R., King L.M.,
RA   Leal B., Lebow H., Lee S., LeVan J.M., Lewis L.C., London P.,
RA   Lorensuhewa L.M., Loulseged H., Lovett D.A., Lucier A., Lucier R.L.,
RA   Ma J., Madu R.C., Mapua P., Martindale A.D., Martinez E., Massey E.,
RA   Mawhiney S., Meador M.G., Mendez S., Mercado C., Mercado I.C.,
RA   Merritt C.E., Miner Z.L., Minja E., Mitchell T., Mohabbat F.,
RA   Mohabbat K., Montgomery B., Moore N., Morris S., Munidasa M.,
RA   Ngo R.N., Nguyen N.B., Nickerson E., Nwaokelemeh O.O., Nwokenkwo S.,
RA   Obregon M., Oguh M., Oragunye N., Oviedo R.J., Parish B.J.,
RA   Parker D.N., Parrish J., Parks K.L., Paul H.A., Payton B.A., Perez A.,
RA   Perrin W., Pickens A., Primus E.L., Pu L.-L., Puazo M., Quiles M.M.,
RA   Quiroz J.B., Rabata D., Reeves K., Ruiz S.J., Shao H., Sisson I.,
RA   Sonaike T., Sorelle R.P., Sutton A.E., Svatek A.F., Svetz L.A.,
RA   Tamerisa K.S., Taylor T.R., Teague B., Thomas N., Thorn R.D.,
RA   Trejos Z.Y., Trevino B.K., Ukegbu O.N., Urban J.B., Vasquez L.I.,
RA   Vera V.A., Villasana D.M., Wang L., Ward-Moore S., Warren J.T.,
RA   Wei X., White F., Williamson A.L., Wleczyk R., Wooden H.S.,
RA   Wooden S.H., Yen J., Yoon L., Yoon V., Zorrilla S.E., Nelson D.,
RA   Kucherlapati R., Weinstock G., Gibbs R.A.;
RT   "The finished DNA sequence of human chromosome 12.";
RL   Nature 440:346-351(2006).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [7]
RP   FUNCTION, INTERACTION WITH AKT1, PHOSPHORYLATION AT SER-600 BY AKT1,
RP   AND MUTAGENESIS OF SER-600.
RX   PubMed=12409306; DOI=10.1074/jbc.M206025200;
RA   Suzuki A., Kusakai G., Kishimoto A., Lu J., Ogura T., Lavin M.F.,
RA   Esumi H.;
RT   "Identification of a novel protein kinase mediating Akt survival
RT   signaling to the ATM protein.";
RL   J. Biol. Chem. 278:48-53(2003).
RN   [8]
RP   TISSUE SPECIFICITY.
RX   PubMed=14982852; DOI=10.1016/S0002-9440(10)63186-0;
RA   Kusakai G., Suzuki A., Ogura T., Miyamoto S., Ochiai A., Kaminishi M.,
RA   Esumi H.;
RT   "ARK5 expression in colorectal cancer and its implications for tumor
RT   progression.";
RL   Am. J. Pathol. 164:987-995(2004).
RN   [9]
RP   FUNCTION.
RX   PubMed=15060171; DOI=10.1128/MCB.24.8.3526-3535.2004;
RA   Suzuki A., Lu J., Kusakai G., Kishimoto A., Ogura T., Esumi H.;
RT   "ARK5 is a tumor invasion-associated factor downstream of Akt
RT   signaling.";
RL   Mol. Cell. Biol. 24:3526-3535(2004).
RN   [10]
RP   FUNCTION.
RX   PubMed=15273717; DOI=10.1038/sj.onc.1207963;
RA   Suzuki A., Kusakai G., Kishimoto A., Shimojo Y., Miyamoto S.,
RA   Ogura T., Ochiai A., Esumi H.;
RT   "Regulation of caspase-6 and FLIP by the AMPK family member ARK5.";
RL   Oncogene 23:7067-7075(2004).
RN   [11]
RP   INDUCTION.
RX   PubMed=16044163; DOI=10.1038/sj.onc.1208844;
RA   Suzuki A., Iida S., Kato-Uranishi M., Tajima E., Zhan F., Hanamura I.,
RA   Huang Y., Ogura T., Takahashi S., Ueda R., Barlogie B.,
RA   Shaughnessy J. Jr., Esumi H.;
RT   "ARK5 is transcriptionally regulated by the Large-MAF family and
RT   mediates IGF-1-induced cell invasion in multiple myeloma: ARK5 as a
RT   new molecular determinant of malignant multiple myeloma.";
RL   Oncogene 24:6936-6944(2005).
RN   [12]
RP   INDUCTION.
RX   PubMed=16424013; DOI=10.1158/0008-5472.CAN-05-2154;
RA   Morito N., Yoh K., Fujioka Y., Nakano T., Shimohata H., Hashimoto Y.,
RA   Yamada A., Maeda A., Matsuno F., Hata H., Suzuki A., Imagawa S.,
RA   Mitsuya H., Esumi H., Koyama A., Yamamoto M., Mori N., Takahashi S.;
RT   "Overexpression of c-Maf contributes to T-cell lymphoma in both mice
RT   and human.";
RL   Cancer Res. 66:812-819(2006).
RN   [13]
RP   PHOSPHORYLATION BY STK38L.
RX   PubMed=16488889; DOI=10.1074/jbc.M511354200;
RA   Suzuki A., Ogura T., Esumi H.;
RT   "NDR2 acts as the upstream kinase of ARK5 during insulin-like growth
RT   factor-1 signaling.";
RL   J. Biol. Chem. 281:13915-13921(2006).
RN   [14]
RP   UBIQUITINATION, AND DEUBIQUITINATION BY USP9X.
RX   PubMed=18254724; DOI=10.1042/BJ20080067;
RA   Al-Hakim A.K., Zagorska A., Chapman L., Deak M., Peggie M.,
RA   Alessi D.R.;
RT   "Control of AMPK-related kinases by USP9X and atypical
RT   Lys(29)/Lys(33)-linked polyubiquitin chains.";
RL   Biochem. J. 411:249-260(2008).
RN   [15]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT MET-1, PHOSPHORYLATION [LARGE
RP   SCALE ANALYSIS] AT SER-22; THR-211 AND SER-455, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19369195; DOI=10.1074/mcp.M800588-MCP200;
RA   Oppermann F.S., Gnad F., Olsen J.V., Hornberger R., Greff Z., Keri G.,
RA   Mann M., Daub H.;
RT   "Large-scale proteomics analysis of the human kinome.";
RL   Mol. Cell. Proteomics 8:1751-1764(2009).
RN   [16]
RP   FUNCTION, AND MUTAGENESIS OF LYS-84; THR-211 AND SER-600.
RX   PubMed=19927127; DOI=10.1038/emboj.2009.342;
RA   Humbert N., Navaratnam N., Augert A., Da Costa M., Martien S.,
RA   Wang J., Martinez D., Abbadie C., Carling D., de Launoit Y., Gil J.,
RA   Bernard D.;
RT   "Regulation of ploidy and senescence by the AMPK-related kinase
RT   NUAK1.";
RL   EMBO J. 29:376-386(2010).
RN   [17]
RP   FUNCTION, INTERACTION WITH PPP1CB, DOMAIN GILK, MUTAGENESIS OF
RP   400-ILE-LEU-401, AND PHOSPHORYLATION AT THR-211.
RX   PubMed=20354225; DOI=10.1126/scisignal.2000616;
RA   Zagorska A., Deak M., Campbell D.G., Banerjee S., Hirano M.,
RA   Aizawa S., Prescott A.R., Alessi D.R.;
RT   "New roles for the LKB1-NUAK pathway in controlling myosin phosphatase
RT   complexes and cell adhesion.";
RL   Sci. Signal. 3:RA25-RA25(2010).
RN   [18]
RP   FUNCTION, SUBCELLULAR LOCATION, AND MUTAGENESIS OF LYS-84 AND THR-211.
RX   PubMed=21317932; DOI=10.1038/onc.2011.19;
RA   Hou X., Liu J.E., Liu W., Liu C.Y., Liu Z.Y., Sun Z.Y.;
RT   "A new role of NUAK1: directly phosphorylating p53 and regulating cell
RT   proliferation.";
RL   Oncogene 30:2933-2942(2011).
RN   [19]
RP   FUNCTION, AND INTERACTION WITH CDKN1A.
RX   PubMed=25329316; DOI=10.1371/journal.pgen.1004721;
RA   Esteve-Puig R., Gil R., Gonzalez-Sanchez E., Bech-Serra J.J.,
RA   Grueso J., Hernandez-Losa J., Moline T., Canals F., Ferrer B.,
RA   Cortes J., Bastian B., Cajal S.R.Y., Martin-Caballero J., Flores J.M.,
RA   Vivancos A., Garcia-Patos V., Recio J.A.;
RT   "A mouse model uncovers LKB1 as an UVB-induced DNA damage sensor
RT   mediating CDKN1A (p21WAF1/CIP1) degradation.";
RL   PLoS Genet. 10:E1004721-E1004721(2014).
RN   [20]
RP   VARIANTS [LARGE SCALE ANALYSIS] ASP-419 AND ARG-543.
RX   PubMed=17344846; DOI=10.1038/nature05610;
RA   Greenman C., Stephens P., Smith R., Dalgliesh G.L., Hunter C.,
RA   Bignell G., Davies H., Teague J., Butler A., Stevens C., Edkins S.,
RA   O'Meara S., Vastrik I., Schmidt E.E., Avis T., Barthorpe S.,
RA   Bhamra G., Buck G., Choudhury B., Clements J., Cole J., Dicks E.,
RA   Forbes S., Gray K., Halliday K., Harrison R., Hills K., Hinton J.,
RA   Jenkinson A., Jones D., Menzies A., Mironenko T., Perry J., Raine K.,
RA   Richardson D., Shepherd R., Small A., Tofts C., Varian J., Webb T.,
RA   West S., Widaa S., Yates A., Cahill D.P., Louis D.N., Goldstraw P.,
RA   Nicholson A.G., Brasseur F., Looijenga L., Weber B.L., Chiew Y.-E.,
RA   DeFazio A., Greaves M.F., Green A.R., Campbell P., Birney E.,
RA   Easton D.F., Chenevix-Trench G., Tan M.-H., Khoo S.K., Teh B.T.,
RA   Yuen S.T., Leung S.Y., Wooster R., Futreal P.A., Stratton M.R.;
RT   "Patterns of somatic mutation in human cancer genomes.";
RL   Nature 446:153-158(2007).
CC   -!- FUNCTION: Serine/threonine-protein kinase involved in various
CC       processes such as cell adhesion, regulation of cell ploidy and
CC       senescence, cell proliferation and tumor progression.
CC       Phosphorylates ATM, CASP6, LATS1, PPP1R12A and p53/TP53. Acts as a
CC       regulator of cellular senescence and cellular ploidy by mediating
CC       phosphorylation of 'Ser-464' of LATS1, thereby controlling its
CC       stability. Controls cell adhesion by regulating activity of the
CC       myosin protein phosphatase 1 (PP1) complex. Acts by mediating
CC       phosphorylation of PPP1R12A subunit of myosin PP1: phosphorylated
CC       PPP1R12A then interacts with 14-3-3, leading to reduced
CC       dephosphorylation of myosin MLC2 by myosin PP1. May be involved in
CC       DNA damage response: phosphorylates p53/TP53 at 'Ser-15' and 'Ser-
CC       392' and is recruited to the CDKN1A/WAF1 promoter to participate
CC       to transcription activation by p53/TP53. May also act as a tumor
CC       malignancy-associated factor by promoting tumor invasion and
CC       metastasis under regulation and phosphorylation by AKT1.
CC       Suppresses Fas-induced apoptosis by mediating phosphorylation of
CC       CASP6, thereby suppressing the activation of the caspase and the
CC       subsequent cleavage of CFLAR. Regulates UV radiation-induced DNA
CC       damage response mediated by CDKN1A. In association with STK11,
CC       phosphorylates CDKN1A in response to UV radiation and contributes
CC       to its degradation which is necessary for optimal DNA repair
CC       (PubMed:25329316). {ECO:0000269|PubMed:12409306,
CC       ECO:0000269|PubMed:14976552, ECO:0000269|PubMed:15060171,
CC       ECO:0000269|PubMed:15273717, ECO:0000269|PubMed:19927127,
CC       ECO:0000269|PubMed:20354225, ECO:0000269|PubMed:21317932,
CC       ECO:0000269|PubMed:25329316}.
CC   -!- CATALYTIC ACTIVITY: ATP + a protein = ADP + a phosphoprotein.
CC   -!- COFACTOR:
CC       Name=Mg(2+); Xref=ChEBI:CHEBI:18420;
CC   -!- ENZYME REGULATION: Activated by phosphorylation on Thr-211.
CC       Activated by phosphorylation at Ser-600 AKT1 during glucose
CC       starvation; the relevance of such activation in normal cells is
CC       however unsure. {ECO:0000269|PubMed:14976552}.
CC   -!- SUBUNIT: Interact (via GILK motif) with PPP1CB; the interaction is
CC       direct and bridges NUAK1 and PPP1R12A. Interacts with CDKN1A.
CC       {ECO:0000269|PubMed:25329316}.
CC   -!- INTERACTION:
CC       O95835:LATS1; NbExp=2; IntAct=EBI-1046789, EBI-444209;
CC       P04637:TP53; NbExp=5; IntAct=EBI-1046789, EBI-366083;
CC   -!- SUBCELLULAR LOCATION: Nucleus {ECO:0000269|PubMed:21317932}.
CC       Cytoplasm {ECO:0000269|PubMed:21317932}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1;
CC         IsoId=O60285-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=O60285-2; Sequence=VSP_014236, VSP_014237;
CC         Note=No experimental confirmation available.;
CC   -!- TISSUE SPECIFICITY: Expressed at high levels in heart and brain,
CC       and at lower levels in skeletal muscle, kidney, ovary, placenta,
CC       lung and liver. Highly up-regulated in colorectal cancer cell
CC       lines. {ECO:0000269|PubMed:14982852}.
CC   -!- INDUCTION: Transcriptionally regulated by members of the MAF
CC       family. {ECO:0000269|PubMed:16044163,
CC       ECO:0000269|PubMed:16424013}.
CC   -!- DOMAIN: The GILK motif mediates interaction with PPP1CB.
CC       {ECO:0000269|PubMed:20354225}.
CC   -!- PTM: Ubiquitinated with 'Lys-29'- and 'Lys-33'-linked
CC       polyubiquitins which appear to impede LKB1-mediated
CC       phosphorylation. Deubiquitinated by USP9X.
CC       {ECO:0000269|PubMed:18254724}.
CC   -!- PTM: Phosphorylated at Thr-211 by STK11/LKB1 in complex with
CC       STE20-related adapter-alpha (STRADA) pseudo kinase and CAB39. Not
CC       dephosphorylated by the myosin PP1 complex when regulating its
CC       activity, due to the presence of PPP1R12A, which prevents myosin
CC       PP1 from dephosphorylating NUAK1. Phosphorylated by STK38L upon
CC       stimulation with IGF1. {ECO:0000269|PubMed:14976552,
CC       ECO:0000269|PubMed:20354225}.
CC   -!- SIMILARITY: Belongs to the protein kinase superfamily. CAMK
CC       Ser/Thr protein kinase family. SNF1 subfamily. {ECO:0000305}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=BAA25463.2; Type=Erroneous initiation; Note=Translation N-terminally shortened.; Evidence={ECO:0000305};
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AB011109; BAA25463.2; ALT_INIT; mRNA.
DR   EMBL; AK027302; BAB55026.1; -; mRNA.
DR   EMBL; AK289992; BAF82681.1; -; mRNA.
DR   EMBL; AC010182; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC011595; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CH471054; EAW97768.1; -; Genomic_DNA.
DR   EMBL; BC152462; AAI52463.1; -; mRNA.
DR   CCDS; CCDS31892.1; -. [O60285-1]
DR   RefSeq; NP_055655.1; NM_014840.2. [O60285-1]
DR   UniGene; Hs.524692; -.
DR   ProteinModelPortal; O60285; -.
DR   SMR; O60285; -.
DR   BioGrid; 115221; 23.
DR   IntAct; O60285; 5.
DR   MINT; MINT-6772082; -.
DR   STRING; 9606.ENSP00000261402; -.
DR   BindingDB; O60285; -.
DR   ChEMBL; CHEMBL5784; -.
DR   GuidetoPHARMACOLOGY; 2129; -.
DR   iPTMnet; O60285; -.
DR   PhosphoSitePlus; O60285; -.
DR   BioMuta; NUAK1; -.
DR   EPD; O60285; -.
DR   PaxDb; O60285; -.
DR   PeptideAtlas; O60285; -.
DR   PRIDE; O60285; -.
DR   DNASU; 9891; -.
DR   Ensembl; ENST00000261402; ENSP00000261402; ENSG00000074590. [O60285-1]
DR   GeneID; 9891; -.
DR   KEGG; hsa:9891; -.
DR   UCSC; uc001tlj.2; human. [O60285-1]
DR   CTD; 9891; -.
DR   DisGeNET; 9891; -.
DR   GeneCards; NUAK1; -.
DR   HGNC; HGNC:14311; NUAK1.
DR   HPA; HPA027455; -.
DR   HPA; HPA057143; -.
DR   MIM; 608130; gene.
DR   neXtProt; NX_O60285; -.
DR   OpenTargets; ENSG00000074590; -.
DR   PharmGKB; PA142671242; -.
DR   eggNOG; KOG0611; Eukaryota.
DR   eggNOG; ENOG410XPDM; LUCA.
DR   GeneTree; ENSGT00790000122947; -.
DR   HOGENOM; HOG000004864; -.
DR   HOVERGEN; HBG007160; -.
DR   InParanoid; O60285; -.
DR   KO; K08800; -.
DR   OMA; NRPRPQY; -.
DR   OrthoDB; EOG091G033W; -.
DR   PhylomeDB; O60285; -.
DR   TreeFam; TF324572; -.
DR   Reactome; R-HSA-6804756; Regulation of TP53 Activity through Phosphorylation.
DR   SignaLink; O60285; -.
DR   SIGNOR; O60285; -.
DR   ChiTaRS; NUAK1; human.
DR   GeneWiki; NUAK1; -.
DR   GenomeRNAi; 9891; -.
DR   PRO; PR:O60285; -.
DR   Proteomes; UP000005640; Chromosome 12.
DR   Bgee; ENSG00000074590; -.
DR   CleanEx; HS_NUAK1; -.
DR   ExpressionAtlas; O60285; baseline and differential.
DR   Genevisible; O60285; HS.
DR   GO; GO:0005737; C:cytoplasm; IDA:UniProtKB.
DR   GO; GO:0001650; C:fibrillar center; IDA:HPA.
DR   GO; GO:0015630; C:microtubule cytoskeleton; IDA:HPA.
DR   GO; GO:0005654; C:nucleoplasm; TAS:Reactome.
DR   GO; GO:0005634; C:nucleus; IDA:UniProtKB.
DR   GO; GO:0005524; F:ATP binding; IEA:UniProtKB-KW.
DR   GO; GO:0046872; F:metal ion binding; IEA:UniProtKB-KW.
DR   GO; GO:0002039; F:p53 binding; IPI:UniProtKB.
DR   GO; GO:0004674; F:protein serine/threonine kinase activity; IDA:UniProtKB.
DR   GO; GO:0007155; P:cell adhesion; IEA:UniProtKB-KW.
DR   GO; GO:0006974; P:cellular response to DNA damage stimulus; IEA:UniProtKB-KW.
DR   GO; GO:0035556; P:intracellular signal transduction; IBA:GO_Central.
DR   GO; GO:0006468; P:protein phosphorylation; IDA:UniProtKB.
DR   GO; GO:0030155; P:regulation of cell adhesion; IDA:UniProtKB.
DR   GO; GO:0042127; P:regulation of cell proliferation; TAS:UniProtKB.
DR   GO; GO:2000772; P:regulation of cellular senescence; IDA:UniProtKB.
DR   GO; GO:0035507; P:regulation of myosin-light-chain-phosphatase activity; IDA:UniProtKB.
DR   GO; GO:1901796; P:regulation of signal transduction by p53 class mediator; TAS:Reactome.
DR   InterPro; IPR011009; Kinase-like_dom.
DR   InterPro; IPR000719; Prot_kinase_dom.
DR   InterPro; IPR017441; Protein_kinase_ATP_BS.
DR   InterPro; IPR008271; Ser/Thr_kinase_AS.
DR   Pfam; PF00069; Pkinase; 1.
DR   SMART; SM00220; S_TKc; 1.
DR   SUPFAM; SSF56112; SSF56112; 1.
DR   PROSITE; PS00107; PROTEIN_KINASE_ATP; 1.
DR   PROSITE; PS50011; PROTEIN_KINASE_DOM; 1.
DR   PROSITE; PS00108; PROTEIN_KINASE_ST; 1.
PE   1: Evidence at protein level;
KW   Acetylation; Alternative splicing; ATP-binding; Cell adhesion;
KW   Complete proteome; Cytoplasm; DNA damage; Kinase; Magnesium;
KW   Metal-binding; Nucleotide-binding; Nucleus; Phosphoprotein;
KW   Polymorphism; Reference proteome; Serine/threonine-protein kinase;
KW   Transferase; Ubl conjugation.
FT   CHAIN         1    661       NUAK family SNF1-like kinase 1.
FT                                /FTId=PRO_0000086453.
FT   DOMAIN       55    306       Protein kinase. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00159}.
FT   NP_BIND      61     69       ATP. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00159}.
FT   MOTIF       399    402       GILK motif.
FT   ACT_SITE    178    178       Proton acceptor. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00159, ECO:0000255|PROSITE-
FT                                ProRule:PRU10027}.
FT   BINDING      84     84       ATP. {ECO:0000305}.
FT   MOD_RES       1      1       N-acetylmethionine.
FT                                {ECO:0000244|PubMed:19369195}.
FT   MOD_RES      22     22       Phosphoserine.
FT                                {ECO:0000244|PubMed:19369195}.
FT   MOD_RES     211    211       Phosphothreonine; by LKB1.
FT                                {ECO:0000244|PubMed:19369195,
FT                                ECO:0000269|PubMed:14976552,
FT                                ECO:0000269|PubMed:20354225}.
FT   MOD_RES     455    455       Phosphoserine.
FT                                {ECO:0000244|PubMed:19369195}.
FT   MOD_RES     600    600       Phosphoserine; by PKB/AKT1.
FT                                {ECO:0000269|PubMed:12409306}.
FT   VAR_SEQ     182    208       ENILLDDNCNIKIADFGLSNLYQKDKF -> KKTSRENQVT
FT                                TLPQSAVSLRSCWTVMM (in isoform 2).
FT                                {ECO:0000303|PubMed:14702039}.
FT                                /FTId=VSP_014236.
FT   VAR_SEQ     209    661       Missing (in isoform 2).
FT                                {ECO:0000303|PubMed:14702039}.
FT                                /FTId=VSP_014237.
FT   VARIANT     419    419       G -> D (in dbSNP:rs55774704).
FT                                {ECO:0000269|PubMed:17344846}.
FT                                /FTId=VAR_040963.
FT   VARIANT     543    543       P -> R (in dbSNP:rs3741883).
FT                                {ECO:0000269|PubMed:17344846}.
FT                                /FTId=VAR_017246.
FT   MUTAGEN      84     84       K->A: Abolishes kinase activity and
FT                                ability to induce senescence.
FT                                {ECO:0000269|PubMed:19927127,
FT                                ECO:0000269|PubMed:21317932}.
FT   MUTAGEN     211    211       T->A: Prevents phosphorylation and
FT                                activation by STK11/LKB1 complex.
FT                                Abolishes ability to induce senescence.
FT                                {ECO:0000269|PubMed:14976552,
FT                                ECO:0000269|PubMed:19927127,
FT                                ECO:0000269|PubMed:21317932}.
FT   MUTAGEN     400    401       IL->KK: Abolishes interaction with PPP1CB
FT                                and ability to regulate myosin PP1
FT                                activity. {ECO:0000269|PubMed:20354225}.
FT   MUTAGEN     600    600       S->A: Abrogates phosphorylation by
FT                                PKB/AKT1. Does not affect ability to
FT                                induce senescence.
FT                                {ECO:0000269|PubMed:12409306,
FT                                ECO:0000269|PubMed:19927127}.
FT   CONFLICT     86     86       I -> V (in Ref. 3; BAB55026).
FT                                {ECO:0000305}.
SQ   SEQUENCE   661 AA;  74305 MW;  806F37D52CA4718F CRC64;
     MEGAAAPVAG DRPDLGLGAP GSPREAVAGA TAALEPRKPH GVKRHHHKHN LKHRYELQET
     LGKGTYGKVK RATERFSGRV VAIKSIRKDK IKDEQDMVHI RREIEIMSSL NHPHIISIYE
     VFENKDKIVI IMEYASKGEL YDYISERRRL SERETRHFFR QIVSAVHYCH KNGVVHRDLK
     LENILLDDNC NIKIADFGLS NLYQKDKFLQ TFCGSPLYAS PEIVNGRPYR GPEVDSWALG
     VLLYTLVYGT MPFDGFDHKN LIRQISSGEY REPTQPSDAR GLIRWMLMVN PDRRATIEDI
     ANHWWVNWGY KSSVCDCDAL HDSESPLLAR IIDWHHRSTG LQADTEAKMK GLAKPTTSEV
     MLERQRSLKK SKKENDFAQS GQDAVPESPS KLSSKRPKGI LKKRSNSEHR SHSTGFIEGV
     VGPALPSTFK MEQDLCRTGV LLPSSPEAEV PGKLSPKQSA TMPKKGILKK TQQRESGYYS
     SPERSESSEL LDSNDVMGSS IPSPSPPDPA RVTSHSLSCR RKGILKHSSK YSAGTMDPAL
     VSPEMPTLES LSEPGVPAEG LSRSYSRPSS VISDDSVLSS DSFDLLDLQE NRPARQRIRS
     CVSAENFLQI QDFEGLQNRP RPQYLKRYRN RLADSSFSLL TDMDDVTQVY KQALEICSKL
     N
//
